Good afternoon, everyone, and thank you for joining BridgeBio Pharma's First Quarter 2026 Earnings Call. I'm Chinmay Shukla, Senior Vice President, Strategic Finance. With me are Neil Kumar, our CEO; ...

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and BridgeBio Pharma, Inc. (NASDAQ:BBIO) ranks 2nd on this list. BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a relatively ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...

In "My Game: Tiger Woods-Shot making Secrets," produced by Golf Digest, Tiger takes you through his bag from the driver to the wedges. He explains his strategies, evaluates dozens of shots, and ...

The successful commercialization of Attruby could establish BridgeBio as a key player in the ATTR-CM market, significantly improving its path to profitability.